# Study Identifies Key Enzyme That Could Be Targeted to Fight Brain Cancers

Researchers at Ohio State University Medical Center have identified a key enzyme that may be used to combat one of the deadliest types of brain cancer. Known as PGM3, this enzyme plays a critical role in the hexosamine biosynthesis pathway, which contributes to rapid tumor growth through protein and lipid glycosylation. Targeting PGM3 could significantly improve glioblastoma treatment outcomes.

 Various enterprises like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) focused on brain cancer treatment development are also making progress in…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

 About TinyGems

 TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.TinyGems.com

 Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

 TinyGemsLos Angeles, CAwww.TinyGems.com310.299.1717 Office 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/tg/study-identifies-key-enzyme-that-could-be-targeted-to-fight-brain-cancers/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/key-enzyme-identified-for-fighting-deadly-brain-cancers/48f1917936340e9c981f31744bcbc140) 

 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/254/25/chef9iI3.webp)